SENS-AI
LBR Trading Statement Neutral

LIBSTAR HOLDINGS LIMITED - Trading Statement for the Six Months Ended 30 June 2026

Libstar Holdings Limited
Full analysis

What this filing means

Libstar's H1 earnings are sharply lower as expected: Total EPS is guided down 36.8%–47.4% to 8.0–9.6c and Total HEPS down 18.0%–27.5% to 12.1–13.7c. The critical qualifier is that Normalised HEPS from continuing operations is guided only -2.4% to +2.4% versus the prior year, and Normalised EBITDA is -2.8% to -5.8% — confirming the core business is not broken. The market had already been told the direction and sold off 17.5% into the print, so this is a quantification, not a revelation. The H2 improvement narrative management committed to in June now faces its first real test.

Libstar is reporting much lower earnings for the first half, but most of that fall is because the company had to take write-downs, pay restructuring costs and absorb losses from shutting down a struggling division — not because the ongoing business suddenly got worse. Strip those out and earnings are roughly flat. The share had already fallen before this announcement, so the market was not caught by surprise by the direction. The real question now is whether the second half recovery management promised actually materialises.

Bull case

  • Normalised HEPS from continuing operations is essentially flat (-2.4% to +2.4%) at 23.0–25.4c, while Total HEPS falls 18–27.5%; the operational gap is fully explained by disclosed non-recurring items.
  • Four of seven food sub-categories (Dairy, Value-added Meats, Select Products, Baking) are expected to grow Normalised EBITDA, isolating weakness to two specific categories.
  • Non-recurring drags — R16.3m Dickon Hall impairment, R8.0m PPE scrapping loss, R10.3m FX losses, R12.3m retrenchment costs — are itemised and excluded from Normalised HEPS, framing the Total EPS/HEPS decline as non-structural.
  • Net interest-bearing debt to Normalised EBITDA and Adjusted ROIC are expected to improve year-on-year, signalling balance-sheet resilience even as EBITDA dips modestly.

Bear case

  • Total EPS cratering 36.8%-47.4% to 8.0-9.6c — a collapse more than double the 20% materiality trigger that compels this disclosure.
  • Even the 'clean' Normalised EBITDA declines 2.8%-5.8% to R446.1m-R460.3m, confirming the weakness extends beyond one-offs into the underlying business.
  • Dickon Hall impairments rose to R16.3m with a R8.0m PPE scrapping loss — recurring structural damage at the very asset flagged in the pre-close update.
  • The trading statement is unaudited and omits cash flow, segment-level revenue/margin detail, and any actual debt figure — leaving the 'improving' balance-sheet claim unverified.
  • Retrenchment costs tripled to R12.3m from R3.7m, signalling ongoing restructuring that contradicts the pre-close framing of manageable disruption.
View original SENS announcement

AI-generated summary by SENS-AI, based on the original JSE SENS filing.

SENS-AI conclusion

Total EPS down 36.8%–47.4% and Total HEPS down 18.0%–27.5% are genuinely bad headline numbers, but the analyst's own read that underlying operations are essentially flat (-2.4% to +2.4% Normalised HEPS) is well-supported. The pre-announcement sell-off of 17.5% reflects that the direction was flagged in June, so the magnitude of the miss on total metrics is partly contextualised. The balance-sheet metrics improving even as earnings fall is a constructive offset. The H2 recovery narrative is now the live test. So what: the direction was pre-flagged, the underlying business is resilient, but the market still needs the 8 September interim results to confirm whether the normalisation of one-off drags and the Dickon Hall integration delivers the H2 improvement that was committed to. Missing evidence: No cash-flow or working capital data — full results required; No segmental revenue or margin breakdown beyond EBITDA direction; Unaudited financial information; No precise H2 guidance quantified; Normalised HEPS range crosses zero (-7.3% to +2.4%), limiting directional certainty

The 8 September interim results are where the market will test whether Normalised EBITDA margins and cash conversion support the resilience narrative and the H2 recovery case.

Evidence from the filing

  • Normalised HEPS from continuing operations is essentially flat (-2.4% to +2.4%) at 23.0–25.4c, while Total HEPS falls 18–27.5%; the operational gap is fully explained by disclosed non-recurring items.

    “Normalised HEPS from continuing operations to be between 23.0 and 25.4 cents per share, compared to the prior year Normalised HEPS of 24.8 cents per share (representing a movement of between a 2.4% increase and a 7.3% decrease)”

  • Four of seven food sub-categories (Dairy, Value-added Meats, Select Products, Baking) are expected to grow Normalised EBITDA, isolating weakness to two specific categories.

    “Four of the Group's seven food sub-categories, namely Dairy, Value-added Meats, Select Products and Baking are expected to report growth in Normalised EBITDA, with the Convenience Meals sub-category marginally lower and underperformance concentrated in Dickon Hall Foods (Wet Condiments sub-category) and Dry Condiments”

  • Non-recurring drags — R16.3m Dickon Hall impairment, R8.0m PPE scrapping loss, R10.3m FX losses, R12.3m retrenchment costs — are itemised and excluded from Normalised HEPS, framing the Total EPS/HEPS decline as non-structural.

    “Impairment charges of R16.3 million (H1 2025: R10.4 million) and a loss of R8.0 million (H1 2025: R1.4 million gain) on the scrapping of property, plant and equipment in Dickon Hall Foods were recognised during the period”

  • Net interest-bearing debt to Normalised EBITDA and Adjusted ROIC are expected to improve year-on-year, signalling balance-sheet resilience even as EBITDA dips modestly.

    “the Group's net interest-bearing debt to Normalised EBITDA and twelve-month moving Adjusted ROIC expected to improve relative to the prior corresponding period”

  • Total EPS cratering 36.8%-47.4% to 8.0-9.6c — a collapse more than double the 20% materiality trigger that compels this disclosure.

    “Total Earnings Per Share (EPS) to be between 8.0 and 9.6 cents per share, compared to the prior period EPS of 15.2 cents per share (representing a decrease of between 36.8% and 47.4%)”

  • Even the 'clean' Normalised EBITDA declines 2.8%-5.8% to R446.1m-R460.3m, confirming the weakness extends beyond one-offs into the underlying business.

    “Normalised EBITDA (excluding unrealised foreign currency movements and other non-recurring, non-trading, and non-cash items) of between R446.1 million and R460.3 million. This represents a decrease of between 2.8% and 5.8% compared to the prior period Normalised EBITDA of R473.8 million”

  • The trading statement is unaudited and omits cash flow, segment-level revenue/margin detail, and any actual debt figure — leaving the 'improving' balance-sheet claim unverified.

    “The financial information in this announcement has not been reviewed or reported on by Libstar's external auditors”

  • Retrenchment costs tripled to R12.3m from R3.7m, signalling ongoing restructuring that contradicts the pre-close framing of manageable disruption.

    “Unrealised foreign exchange losses of R10.3 million (H1 2025: R5.3 million gains) and retrenchment costs of R12.3 million (H1 2025: R3.7 million) were recognised during the period”
Category
Trading Statement
Event posture
No Edge
Published
Aug 20, 2026

More on Libstar Holdings Limited

Libstar Holdings Limited (LBR) share price All Libstar Holdings Limited SENS announcements

Related filings